The 2025 guideline introduces notable updates including refined recommendations for dual antiplatelet therapy, cardiogenic ...

Tiffany Meng, PharmD, oncology pharmacist, UCSF Health, discusses ways that pharmacists can help guide patients to financial ...

Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...

Mile Brujic, OD, FAAO, discusses his new research being presented at the Southeastern Educational Congress of Optometry 2025 ...

During the Southeastern Educational Congress of Optometry (SECO) 2025 meeting held from February 27 to March 2, 2025, in ...

Selective laser trabeculoplasty, artificial intelligence–driven diagnostics, and new drug delivery systems are transforming ...

Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage ...

Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with ...

Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes ...

Food recalls numbered 300 in 2024, indicating that increased vigilance may be required from both consumers and the FDA.

Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), especially in ...

Panelist discusses how organizations can justify the cost of Centers of Excellence for HS by improving patient outcomes, reducing complications, and enhancing care efficiency. Metrics for evaluating ...